… to the disease signature. Our work defines a robust genetic signature for IPF providing a …
as enables the identification of preclinical models that most closely resemble human IPF. …

… Volcano plots depicting features that are statistically significant in idiopathic pulmonary
fibrosis (IPF) lung tissue compared with control lung tissue at a false discovery rate <0.05 (blue …

… Therefore, we constructed a molecular genomic signature to predict the prognosis of IPF …
the performance of the genomic signature in the validation cohort. The signature showed an …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition with poor survival times. We
previously published a genome-… size estimates, we performed a genome-wide meta-analysis …

… nintedanib, for treatment of patients with idiopathic pulmonary fibrosis (IPF). However, neither
… minimal effect on IPF-specific gene signature or alter translational modifications involved in …

… Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease characterized by epithelial
injury and chronic activation of invasive fibroblasts that deposit and remodel the extracellular …

… translational biomarker studies. Transcriptomic and proteomic disease signatures generated
from clinically relevant human … ” modeling can enable translational disease understanding, …

… the most common forms of pulmonary fibrosis and to review the most recent advances in
translational study in this area. This review will focus on idiopathic pulmonary fibrosis (IPF), one …

… Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis
(IPF), non-specific interstitial pneumonia (NSIP) and organ donors. J Proteomics. 2013;85:…

… In addition, our findings provide evidence of novel genetic loci associated with ILAs, but
not with IPF. These findings provide further evidence that the DPP9, DSP, FAM13A, IVD, and …